Patents by Inventor John Galloway Anderson

John Galloway Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11730838
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: August 22, 2023
    Assignee: UNIVERSITY OF STRATHCLYDE
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor
  • Publication number: 20210236670
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Application
    Filed: February 17, 2021
    Publication date: August 5, 2021
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor
  • Patent number: 10953117
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: March 23, 2021
    Assignee: University of Strathclyde
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor
  • Publication number: 20180154027
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Application
    Filed: November 8, 2017
    Publication date: June 7, 2018
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor
  • Patent number: 9839706
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: December 12, 2017
    Assignee: University of Strathclyde
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor
  • Publication number: 20150182646
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Application
    Filed: March 13, 2015
    Publication date: July 2, 2015
    Applicant: UNIVERSITY OF STRATHCLYDE
    Inventors: John Galloway Anderson, Michelle MacLean, Gerald Alexander Woolsey, Scott John MacGregor
  • Patent number: 9039966
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: May 26, 2015
    Assignee: University of Strathclyde
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor
  • Publication number: 20080305004
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Application
    Filed: July 28, 2006
    Publication date: December 11, 2008
    Applicant: University of Strathclyde
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor